These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4975759)

  • 21. Protirelin (thyrotropin-releasing hormone) in thyroid gland: possible involvement in regulation of thyroid status.
    Smyth DG; del Rio-Garcia J; Wallnöfer H; Gogl H; Simma W; Huber A; Embacher R; Fraser H; Kreil G
    Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):289-91. PubMed ID: 10452110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical usefulness of radioimmunoassay of thyrotropin: a review.
    Broughton A
    South Med J; 1976 Jun; 69(6):702-4. PubMed ID: 819995
    [No Abstract]   [Full Text] [Related]  

  • 23. [Iodine deficiency disorders with functional autonomy. Diagnostic and therapeutic indications].
    Emrich D
    Nuklearmedizin; 1999; 38(1):3-5. PubMed ID: 9987774
    [No Abstract]   [Full Text] [Related]  

  • 24. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method].
    Bonnyns M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):845-52. PubMed ID: 5709509
    [No Abstract]   [Full Text] [Related]  

  • 25. Thyrotropin-releasing hormone test and the diagnosis of dysthyroid ophthalmopathy.
    Spoor TC; Kennerdell JS
    Ann Ophthalmol; 1981 Apr; 13(4):443-5. PubMed ID: 6787969
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of amiodarone on thyroid hormone economy.
    Posner J; Sobel RJ; Glick S
    Isr J Med Sci; 1984 Feb; 20(2):113-7. PubMed ID: 6423565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of thyroid function with hormone assays.
    Liewendahl K
    Ann Chir Gynaecol; 1983; 72(3):84-9. PubMed ID: 6414358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The TRH test in latent thyroid pathology].
    De Remigis P; Damiani A; Vianale L; D'Angelo M; Bonaduce S; Della Loggia F; Basilico L; Sensi S
    Boll Soc Ital Biol Sper; 1982 Jun; 58(11):663-5. PubMed ID: 6810907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relation between the exophthalmos producing factor (EPF) and thyroid antibodies].
    Kreysing G; Schemmel K; Weisbecker L; Uthgenannt H; Müller W; Kirmse L
    Schweiz Med Wochenschr; 1968 Jun; 98(23):852-4. PubMed ID: 5666557
    [No Abstract]   [Full Text] [Related]  

  • 30. [Understanding disorders in the regulatory cycle of the thyroid. Significance for diagnosis and therapy].
    Heilmann W; Heberling HJ
    Z Gesamte Inn Med; 1981 Mar; 36(5):267-70. PubMed ID: 6787814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 32. [The interrelationship between thyroid gland, psychology and psychiatry].
    Bonet JL
    Vertex; 2001; 12 Suppl 2():17-22. PubMed ID: 11780164
    [No Abstract]   [Full Text] [Related]  

  • 33. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 34. Thyrotropin releasing hormone in clinical practice.
    Ontjes DA
    N C Med J; 1983 Apr; 44(4):211-4. PubMed ID: 6406913
    [No Abstract]   [Full Text] [Related]  

  • 35. [Urinary hydroxyproline in thyroid dysfunction].
    Zbranca Toporaş E; Papp E
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(3):619-24. PubMed ID: 5110804
    [No Abstract]   [Full Text] [Related]  

  • 36. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
    Strumia E
    Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hyperthyroidism with unusual thyroid stimulator detected in the pituitary gland].
    Koshiji Y; Hachiya K; Yoshimura G; Fujiwara M; Tanaka J
    Horumon To Rinsho; 1973 Mar; 21(3):317-21. PubMed ID: 4200112
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
    Bech K
    Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hyperthyroidism and subjects hyperresponding to thyrotropin. Importance of simultaneous thyrotropin and prolactin determination following administration of thyroid-releasing hormone].
    Schlienger JL; De Laharpe F; Reville P; Stephan F
    Sem Hop; 1980 May 8-15; 56(17-18):827-31. PubMed ID: 6248964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.
    Beall GN; Solomon DH
    J Clin Invest; 1966 Apr; 45(4):552-61. PubMed ID: 5937026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.